158 related articles for article (PubMed ID: 31686319)
21. Genome editing and plant transformation of solanaceous food crops.
Van Eck J
Curr Opin Biotechnol; 2018 Feb; 49():35-41. PubMed ID: 28800419
[TBL] [Abstract][Full Text] [Related]
22. Non-viral delivery of genome-editing nucleases for gene therapy.
Wang M; Glass ZA; Xu Q
Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
[TBL] [Abstract][Full Text] [Related]
23. The multiplexed CRISPR targeting platforms.
Cao J; Xiao Q; Yan Q
Drug Discov Today Technol; 2018 Aug; 28():53-61. PubMed ID: 30205881
[TBL] [Abstract][Full Text] [Related]
24. A new era of gene editing for the treatment of human diseases.
Kc M; Steer CJ
Swiss Med Wkly; 2019 Jan; 149():w20021. PubMed ID: 30685869
[TBL] [Abstract][Full Text] [Related]
25. New Gene-Editing Tool Slowly Advances Into the Clinic.
Jenks S
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117363
[No Abstract] [Full Text] [Related]
26. Genetic Modification for Wheat Improvement: From Transgenesis to Genome Editing.
Borisjuk N; Kishchenko O; Eliby S; Schramm C; Anderson P; Jatayev S; Kurishbayev A; Shavrukov Y
Biomed Res Int; 2019; 2019():6216304. PubMed ID: 30956982
[TBL] [Abstract][Full Text] [Related]
27. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
Luo J
Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
[No Abstract] [Full Text] [Related]
28. Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9.
Baylis F
Clin Chem; 2018 Mar; 64(3):489-491. PubMed ID: 29490999
[No Abstract] [Full Text] [Related]
29. The Regulatory Status of Genome-edited Crops.
Wolt JD; Wang K; Yang B
Plant Biotechnol J; 2016 Feb; 14(2):510-8. PubMed ID: 26251102
[TBL] [Abstract][Full Text] [Related]
30. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found.
Carlson B
Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891
[No Abstract] [Full Text] [Related]
31. Base Editing: Efficient Installation of Point Mutations with Minimal Byproducts.
Newby GA
Stem Cells Dev; 2019 Jun; 28(11):712-713. PubMed ID: 31107171
[No Abstract] [Full Text] [Related]
32. The Future of Genome Editing.
Cell; 2018 May; 173(6):1311-1313. PubMed ID: 29856947
[TBL] [Abstract][Full Text] [Related]
33. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.
Chadwick AC; Musunuru K
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):12-18. PubMed ID: 28838920
[TBL] [Abstract][Full Text] [Related]
35. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle CF; MacLaren RE
Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519
[TBL] [Abstract][Full Text] [Related]
36. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
Hohmann S
Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
[No Abstract] [Full Text] [Related]
37. A Roadmap toward Large-Scale Genome Editing in Crops.
Salomé PA
Plant Cell; 2020 May; 32(5):1340-1341. PubMed ID: 32102843
[No Abstract] [Full Text] [Related]
38. Targeted Genome Editing in Genes and cis-Regulatory Regions Improves Qualitative and Quantitative Traits in Crops.
Li X; Xie Y; Zhu Q; Liu YG
Mol Plant; 2017 Nov; 10(11):1368-1370. PubMed ID: 29079543
[No Abstract] [Full Text] [Related]
39. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
Lin WV; Stout JT; Weng CY
Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
[No Abstract] [Full Text] [Related]
40. New plant breeding technologies for food security.
Zaidi SS; Vanderschuren H; Qaim M; Mahfouz MM; Kohli A; Mansoor S; Tester M
Science; 2019 Mar; 363(6434):1390-1391. PubMed ID: 30923209
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
